Ribometrix

Ribometrix is a platform therapeutics company focused on discovering and developing novel small molecule medicines that target RNA structures to treat human diseases. Headquartered in Research Triangle Park, Durham, North Carolina, with additional offices in Chapel Hill and Boston, Ribometrix operates in the biopharmaceutical sector. The company primarily serves patients with unmet medical needs by targeting complex RNA structures, which are pivotal in various diseases. Ribometrix's business model revolves around early-stage drug discovery and development, leveraging its proprietary technology to identify and characterize RNA targets. The company generates revenue through partnerships, licensing agreements, and potential future sales of its therapeutic products. Ribometrix's team includes highly motivated scientists and researchers dedicated to advancing RNA-targeted therapies. The company collaborates extensively within its internal teams and with external partners to drive innovation and bring new treatments to market.

Keywords: RNA-targeted, small molecule medicines, drug discovery, biopharmaceutical, Research Triangle Park, novel therapeutics, unmet medical needs, proprietary technology, licensing agreements, innovation.